BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 18729014)

  • 21. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
    Hafeez F; Razzaq MA; Levine RL; Ramirez MA
    J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic hypothermia for acute ischemic stroke.
    Froehler MT; Ovbiagele B
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):593-603. PubMed ID: 20397832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventional stroke therapy: the potential benefit of direct intra-arterial infusion.
    Connors JJ
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S92-9. PubMed ID: 12556748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving therapeutic approaches to treating acute ischemic stroke.
    Weinberger JM
    J Neurol Sci; 2006 Nov; 249(2):101-9. PubMed ID: 17005205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute ischemic stroke: overview of recent therapeutic developments.
    Suwanwela N; Koroshetz WJ
    Annu Rev Med; 2007; 58():89-106. PubMed ID: 17217327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: comparison with tissue plasminogen activator.
    Furuichi Y; Maeda M; Matsuoka N; Mutoh S; Yanagihara T
    Exp Neurol; 2007 Mar; 204(1):138-46. PubMed ID: 17169359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic management of ischemic stroke: relevance to stem cell therapy.
    Gilman S
    Exp Neurol; 2006 May; 199(1):28-36. PubMed ID: 16631744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraarterial thrombolysis for acute ischemic stroke.
    Jahan R; Vinuela F
    Adv Neurol; 2003; 92():383-7. PubMed ID: 12760204
    [No Abstract]   [Full Text] [Related]  

  • 32. Intra-arterial thrombolysis in acute ischemic stroke: a review of pharmacologic approaches.
    Pettersen JA; Hudon ME; Hill MD
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):285-99. PubMed ID: 15151476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute ischemic stroke update.
    Baldwin K; Orr S; Briand M; Piazza C; Veydt A; McCoy S
    Pharmacotherapy; 2010 May; 30(5):493-514. PubMed ID: 20412000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing therapy for acute ischemic stroke.
    Fisher M
    Therapie; 2002; 57(6):564-8. PubMed ID: 12666264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of arterial collateralization and its relevance to intra-arterial therapy for acute ischemic stroke.
    Ramaiah SS; Mitchell P; Dowling R; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):399-407. PubMed ID: 23601372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of Intra-arterial Therapy for Acute Ischemic Stroke in The Netherlands: MR CLEAN Pretrial Experience.
    Rozeman AD; Wermer MJ; Vos JA; Lycklama à Nijeholt GJ; Beumer D; Berkhemer OA; Dippel DW; Algra A; Boiten J; Schonewille WJ;
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):115-21. PubMed ID: 26456200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New options in the therapeutic management of acute ischaemic stroke. Good results with combined i. v. and i. a. lysis and mechanical thrombectomy].
    Venker C; Stracke P; Berlit P; Diehl RR; Kurre W; Sorgenfrei U; Krämer M; Chapot R
    Fortschr Neurol Psychiatr; 2010 Nov; 78(11):652-7. PubMed ID: 21069630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.